Online Database of Chemicals from Around the World

Peracetylated beta-cyclodextrin
[CAS# 23739-88-0]

List of Suppliers
Shanghai Daji Medical Technology Co., Ltd. China Inquire
www.djpharm.com
+86 13816245196
sales1@djpharm.com
Chemical distributor since 2019
chemBlink Standard supplier since 2025

Identification
ClassificationBiochemical >> Carbohydrate >> Oligosaccharide
NamePeracetylated beta-cyclodextrin
Synonyms[(1R,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecaacetyloxy-10,15,20,25,30,35-hexakis(acetyloxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methyl acetate
Molecular StructureCAS # 23739-88-0, Peracetylated beta-cyclodextrin
Molecular FormulaC84H112O56
Molecular Weight2017.75
CAS Registry Number23739-88-0
SMILESCC(=O)OC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3OC(=O)C)OC(=O)C)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4OC(=O)C)OC(=O)C)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5OC(=O)C)OC(=O)C)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6OC(=O)C)OC(=O)C)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7OC(=O)C)OC(=O)C)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8OC(=O)C)OC(=O)C)COC(=O)C)COC(=O)C)COC(=O)C)COC(=O)C)COC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C
Properties
Density1.5±0.1 g/cm3 Calc.*
Boiling point1361.8±65.0 °C 760 mmHg (Calc.)*
Flash point444.8±34.3 °C (Calc.)*
Index of refraction1.545 (Calc.)*
*Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbolssymbol   GHS07 Warning  Details
Risk StatementsH302-H315-H319-H335  Details
Safety StatementsP261-P305+P351+P338  Details
SDSAvailable
up Discovery and Applications
Peracetylated beta-cyclodextrin is a chemically modified derivative of beta-cyclodextrin in which all the hydroxyl groups on the glucose units are converted to acetate esters. Beta-cyclodextrin itself is a cyclic oligosaccharide composed of seven D-glucose units linked by α-1,4-glycosidic bonds, forming a toroidal structure with a hydrophobic cavity and hydrophilic outer surface. Acetylation of the hydroxyl groups enhances the compound’s solubility in organic solvents, reduces hydrogen-bonding interactions, and alters its inclusion properties, making it useful in various chemical and pharmaceutical applications.

The synthesis of peracetylated beta-cyclodextrin generally involves the reaction of beta-cyclodextrin with acetic anhydride in the presence of a base or catalyst, such as pyridine or dimethylaminopyridine. Complete acetylation requires careful control of reaction time and stoichiometry to ensure that all primary and secondary hydroxyl groups are esterified, producing a uniform peracetylated product. The resulting derivative can be purified by recrystallization from organic solvents or by precipitation, yielding a solid material suitable for further chemical modification or application.

In organic synthesis, peracetylated beta-cyclodextrin is used as an intermediate for selective functionalization of the cyclodextrin scaffold. The acetate groups protect the hydroxyls, allowing chemists to introduce additional substituents at specific positions via selective deprotection and derivatization. This property enables the preparation of various cyclodextrin derivatives with tailored solubility, binding affinities, and steric properties, which are valuable in supramolecular chemistry and host–guest complexation studies.

In pharmaceutical research, peracetylated beta-cyclodextrin is used to modify the solubility and bioavailability of guest molecules through inclusion complex formation. The acetylated derivative retains the hydrophobic cavity characteristic of cyclodextrins but exhibits altered surface properties, which can influence interactions with drugs, lipophilic compounds, and other organic molecules. These complexes are employed to enhance drug stability, control release profiles, and improve transport across biological membranes.

Peracetylated beta-cyclodextrin also finds applications in material science and catalysis. The derivative can serve as a building block for supramolecular assemblies, polymer conjugates, and functionalized nanomaterials. Its hydrophobic interior and acetylated exterior allow for selective encapsulation of guest molecules while maintaining solubility in organic media. In catalysis, modified cyclodextrins are used to create chiral environments for asymmetric reactions and to stabilize transition states through host–guest interactions.

Physically, peracetylated beta-cyclodextrin is typically obtained as a crystalline or amorphous solid with good solubility in organic solvents such as chloroform, dichloromethane, and dimethylformamide. It is stable under standard laboratory conditions but should be protected from strong acids, bases, and prolonged exposure to moisture, which could hydrolyze the acetate esters. Proper handling ensures the integrity of the compound for synthetic, pharmaceutical, and material applications.

Overall, peracetylated beta-cyclodextrin is a versatile modified cyclodextrin featuring acetyl-protected hydroxyl groups on a seven-glucose cyclic scaffold. Its chemical stability, solubility in organic media, and ability to form inclusion complexes make it an important intermediate and functional material for applications in organic synthesis, drug formulation, supramolecular chemistry, and materials science.

References

2023. Thermodynamics of Sorption of Organic Compounds by Sorbents Based on Supramolecular Liquid Crystal HPFAB and β-Cyclodextrin Derivatives under Gas Chromatography Conditions. Protection of Metals and Physical Chemistry of Surfaces, 57(6).
DOI: 10.1134/s2070205123701277

2019. Enhanced Nanoencapsulation of Sepiapterin within PEG-PCL Nanoparticles by Complexation with Triacetyl-Beta Cyclodextrin. Molecules, 24(15).
DOI: 10.3390/molecules24152715

2008. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin. European Journal of Pharmaceutics and Biopharmaceutics, 68(2).
DOI: 10.1016/j.ejpb.2007.06.004
Market Analysis Reports
List of Reports Available for Peracetylated beta-cyclodextrin
Related Products
Peptide YY (Can...  Peptide YY huma...  Peptide YY (3-3...  Peptide YY (13-...  Peptidylarginin...  Peptidylprolyl ...  Peptone  Peptone from so...  Peptone from ve...  Peptones  Peraclopone  Peradoxime  Perakine  Peraksine  Peralopride  Per-6-amino-6-d...  Peramivir  Peramivir trihy...  Perampanel  Perampanel hydr...